ProxyMiner / Company

ASHLAND INC.ASH

Latest proxy: 2025 · view on SEC ↗ · CIK 0001674862

↓ Export PDF

← All companies

CEO total pay

$7,907,423

Guillermo Novo · 2025

Say on pay

Not disclosed

Use Ask for the underlying narrative

CEO pay ratio

Not in CD&A

Median employee: $95,293

Compensation committee

CD&A

Compensation Committee

Per the latest proxy

Filings indexed: 2 · 2025 · 2024

Executive pay

What did they pay them?

From the Summary Compensation Table. Pay mix and YoY are computed from these rows.

Executive	Role	TotalYoY	Pay mix	Salary	Stock	Cash incentive	Other
Guillermo Novo2025 compensation	Chair and Chief Executive Officer	$7,907,423↓ 12%	83% at-risk	$1,152,332	$5,233,863	$1,313,830	$207,398
J. Kevin Willis2025 compensation	SVP, Chief Financial Officer	$2,407,328↓ 21%	75% at-risk	$496,943	$1,455,194	$354,333	$100,859
William Whitaker2025 compensation	SVP and Chief Financial Officer	$2,350,368	85% at-risk	$323,475	$1,748,658	$243,686	$34,549
Alessandra Faccin Assis2025 compensation	SVP & GM Life Sciences & Intermediates	$2,086,178↑ 4%	51% at-risk	$500,347	$776,798	$286,146	$522,888
Osama M. Musa2025 compensation	SVP, Chief Technology Officer	$1,743,822↓ 9%	67% at-risk	$520,185	$807,638	$355,852	$60,147
Karl Bostaph2025 compensation	SVP, Operations	$1,536,524↓ 5%	42% at-risk	$383,869	$412,919	$236,504	$503,232
James P. Minicucci2025 compensation	SVP & GM Personal Care	$1,421,501	64% at-risk	$457,460	$591,839	$311,409	$60,793

Pay mix: base cash incentive equity other

Add to peer comparison →Year-over-year diff →

CD&A excerpt

Compensation discussion & analysis

Opening passage of the loaded filing's CD&A. Use Ask below to query the full text with citations.

This Compensation Discussion and Analysis (“CD&A”) provides a detailed description of our executive compensation philosophy and programs and the compensation decisions made by the Compensation Committee under those programs. This CD&A focuses on the compensation of our named executive officers (“NEOs”) for fiscal 2025, who were: Name Title Guillermo Novo Chair of the Board and Chief Executive Officer (“CEO”) William Whitaker Senior Vice President and Chief Financial Officer (“CFO”) Alessandra Faccin Assis Senior Vice President and GM Life Sciences and Intermediates Dr. Osama M. Musa Senior Vice President and Chief Technology Officer James Minicucci Senior Vice President and GM Personal Care Karl Bostaph(1) Former Senior Vice President Operations J. Kevin Willis(2) Former Senior Vice President and Chief Financial Officer (1)Karl Bostaph retired from Ashland on October 1, 2025. (2)J. Kevin Willis resigned from Ashland on May 16, 2025. fiscal year 2025 performance highlights and financial results Key financial results for fiscal 2025 include: oSales of $1,824 million in fiscal 2025 compared to $2,113 million in fiscal 2024. Portfolio Optimization initiatives including the curtailment …

Read the full CD&A on SEC.gov ↗

Peer comparison

Who they benchmark against

Click any peer to jump to their proxy. Peers we haven't ingested yet kick off an import on click.

Governance

Policy guardrails

hedging
prohibited
“Anti-Hedging and Pledging Policy We prohibit our executive officers from hedging or pledging Ashland securities”
pledging
prohibited
“Anti-Hedging and Pledging Policy We prohibit our executive officers from hedging or pledging Ashland securities”
clawback
present
“clawback policy”
stock ownership guidelines
present
“Stock Ownership Guidelines Our guidelines require executive officers to maintain an amount of equity equal to a multiple of base salary: (i) five times base salary for the CEO and (ii) three times base salary for all oth…”
change in control
change in control agreements
“change in control agreements”
compensation consultant
independent
“independent compensation consultant, Meridian Compensation Partners”
compensation committee
Compensation Committee
“Compensation Committee verifies performance before payout Formulaic”

Performance markers

Metric facts

revenue
—
“creation Adjusted Earnings Per Share (“aEPS”)(1) •Measures ongoing operational performance (1)Adjusted EBITDA and Innovation Revenue, in each case, as used for purposes of our Annual Incentive Plan, and RONA and Adjusted…”
operating income
$401
“Additives (254) Intermediates 21 Unallocated and other(2) (273) $(538) Adjusted EBITDA(1) Life Sciences $193 Personal Care 158 Specialty Additives 94 Intermediates 21 Unallocated and other (65) $401 (1) EBITDA and Adjust…”
median employee compensation
$95,293
“Wall Street Reform and Consumer Protection Act, and Item 402(u) of SEC Regulation S-K, we are providing the following information about the relationship of the annual total compensation of our employees and the annual to…”

Ask

Anything about ASHLAND INC.’s 2025 proxy

Answers are grounded in the loaded filing and cite specific artifacts. Bring your own free Google AI Studio key.

Loading the Ask interface…